US 11059896
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted A61KA61K39/39591A61K47/183
Quick answer
US patent 11059896 (Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61K, A61K39/39591, A61K47/183, A61K9/0019, A61P